Patent fees for research vaccines in the United States

1989 September 1 1, Roy? The final transaction price was $7 million, and Mr. Oye Ross transferred the world's most advanced patent for hepatitis B vaccine production to China. At that time, hepatitis B was the second leading cause of death in China, with US$ 7 million, which was an ideal price acceptable to China at that time.